Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vascular Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 90 articles: HTML format

Single Articles

June 2025
1. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
   Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
   Eur Heart J. 2025;46:2052-2062.
   PubMed     Abstract available
   
   
   
2. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
   Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
   Eur Heart J. 2025;46:2092-2100.
   PubMed     Abstract available
   
   
   May 2025
3. MONTANARO C, Arvanitaki A, Kerrigan W, Kadani Z, et al
   The Fontan Adult Brompton clinical score and mortality risk.
   Eur Heart J. 2025;46:1933-1945.
   PubMed     Abstract available
   
   
   
4. POUNCEY AL, Sweeting MJ, Bicknell C, Powell JT, et al
   Sex-specific differences in alive hospital discharge following infrarenal abdominal aortic aneurysm repair.
   Eur Heart J. 2025;46:1705-1716.
   PubMed     Abstract available
   
   
   
5. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
   Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
   Eur Heart J. 2025;46:1586-1599.
   PubMed     Abstract available
   
   
   
6. ZHANG Q, Li H, Zhuang T, Xu L, et al
   CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
   Eur Heart J. 2025;46:1645-1658.
   PubMed     Abstract available
   
   
   March 2025
7. JIA P, Zhao G, Huang Y, Zou Z, et al
   Remote ischaemic pre-conditioning, kidney injury, and outcomes after coronary angiography and intervention: a randomized trial.
   Eur Heart J. 2025 Mar 11:ehaf135. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. CALAFIORE AM, Prapas S, Gaudino M
   Arterial conduits for coronary bypass grafting: the set-point concept.
   Eur Heart J. 2025;46:922-925.
   PubMed     Abstract available
   
   
   February 2025
9. THELIN S, Modrau IS, Duvernoy O, Dalen M, et al
   No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial.
   Eur Heart J. 2025 Feb 19:ehaf018. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2025
10. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    December 2024
11. FERREIRA D, Hardy J, Meere W, Butel-Simoes L, et al
    Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial.
    Eur Heart J. 2024;45:4990-4998.
    PubMed     Abstract available
    
    
    November 2024
12. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    PubMed     Abstract available
    
    
    
14. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    PubMed     Abstract available
    
    
    October 2024
15. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
    Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
    Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
18. LIU W, Cui C, Wang B
    Six-vessel fenestrated physician-modi fi ed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm.
    Eur Heart J. 2024;45:3765.
    PubMed    
    
    
    
19. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    PubMed    
    
    
    
20. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
21. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    PubMed    
    
    
    
23. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    PubMed    
    
    
    
24. KO YG, Lee SJ, Ahn CM, Lee SH, et al
    Intravascular ultrasound-guided drug-coated balloon angioplasty for femoropopliteal artery disease: a clinical trial.
    Eur Heart J. 2024;45:2839-2847.
    PubMed     Abstract available
    
    
    
25. RICHTER M, Venkiteswaran VK, de Vries JP, Misra S, et al
    APOLLO: advanced magnetic probes for minimally invasive endovascular interventions.
    Eur Heart J. 2024;45:2589-2591.
    PubMed    
    
    
    
26. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    
    
    
    July 2024
27. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    
    
    
    
30. AHMAD Y, Lansky AJ
    Periprocedural myocardial infarction: thresholds of (in)significance.
    Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
    PubMed    
    
    
    
31. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
    Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    PubMed    
    
    
    
33. GE Y, Zhang H, Guo W
    First in man: blocking the false lumen backflow of aortic dissection after thoracic endovascular aortic repair by an off-the-shelf EndoSeal system.
    Eur Heart J. 2024;45:2461.
    PubMed    
    
    
    
34. GOROG DA
    Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters.
    Eur Heart J. 2024;45:2232-2234.
    PubMed    
    
    
    June 2024
35. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
    Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
    Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
    Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. COUGHLAN JJ, Durand R, Byrne RA
    An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
    Eur Heart J. 2024;45:2063-2065.
    PubMed    
    
    
    
39. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available
    
    
    
40. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    
    
    
    May 2024
41. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    PubMed    
    
    
    
46. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    PubMed     Abstract available
    
    
    
47. ROFFI M, Meier B, Gallino A
    Fifty years of percutaneous transluminal angioplasty.
    Eur Heart J. 2024;45:1779-1780.
    PubMed    
    
    
    
48. GRIMALDI S, Migliorini P, Puxeddu I, Rossini R, et al
    Aspirin hypersensitivity: a practical guide for cardiologists.
    Eur Heart J. 2024;45:1716-1726.
    PubMed     Abstract available
    
    
    
49. LEE YJ, Shin S, Kwon SW, Suh Y, et al
    Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
    Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. ABOYANS V, De Carlo M
    Caring for patients with lower extremity artery disease: going beyond stents and bypass grafts.
    Eur Heart J. 2024;45:1644-1646.
    PubMed    
    
    
    
52. SHIBA M, Fukutome K, Higuchi Y
    Involvement of cholesterol crystals in the mechanism of aortogenic cerebral infarction: an angioscopic study.
    Eur Heart J. 2024;45:1686.
    PubMed    
    
    
    
53. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    PubMed    
    
    
    April 2024
54. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    PubMed    
    
    
    
55. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    PubMed    
    
    
    
56. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
    Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
    Eur Heart J. 2024;45:1285.
    PubMed    
    
    
    
57. MATSUMURA H, Yashima F, Shimoji K
    Spontaneous kissing stent for total occlusion of the left main trunk complicated by Stanford Type A aortic dissection.
    Eur Heart J. 2024;45:1179.
    PubMed    
    
    
    March 2024
58. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    
    
    
    
59. VERGALLO R, Galiuto L
    Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
    Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
    PubMed    
    
    
    February 2024
60. IKEDA R, Hiraoka A, Yoshitaka H
    Rupture of a 34-year-old Dacron graft after descending aortic replacement.
    Eur Heart J. 2024;45:636.
    PubMed    
    
    
    
61. XIE Y, Yang P, Hu J
    Off-the-shelf use of a novel unibody single-branched stent for open repair of a double chimney graft-induced retrograde type A aortic dissection.
    Eur Heart J. 2024;45:635.
    PubMed    
    
    
    
62. TARANTINI G, Putorti F, Nai Fovino L
    10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds.
    Eur Heart J. 2024;45:556.
    PubMed    
    
    
    
63. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    
    
    
    January 2024
64. SENIOR R, Khattar RS
    To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
    Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
    PubMed    
    
    
    
65. NAKAJIMA A, Okutsu M, Nakamura S
    Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy.
    Eur Heart J. 2024;45:315.
    PubMed    
    
    
    
66. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. CAPRANZANO P, Moliterno D, Capodanno D
    Aspirin-free antiplatelet strategies after percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 18:ehad876. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. HAMILTON DE, Albright J, Seth M, Painter I, et al
    Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Eur Heart J. 2024 Jan 17:ehad836. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. VERGALLO R, Galiuto L
    Shedding the optical coherence tomography light on the treatment of complex coronary bifurcation lesions.
    Eur Heart J. 2024;45:159-160.
    PubMed    
    
    
    
70. COSTA F, Montalto C, Valgimigli M
    One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?
    Eur Heart J. 2024;45:71-72.
    PubMed    
    
    
    December 2023
71. BRIGNOLE M, Deharo JC
    Different techniques of venous access for CIEDs: advantages and disadvantages.
    Eur Heart J. 2023;44:4859-4861.
    PubMed    
    
    
    
72. ALFONSO F, Marschall A, Rivero F
    Revascularization for left main coronary artery disease.
    Eur Heart J. 2023;44:4893.
    PubMed    
    
    
    
73. PERSSON J, Ivert T, Omerovic E
    Observational studies are needed to complete the body of evidence for left main coronary artery disease revascularization strategies.
    Eur Heart J. 2023;44:4894.
    PubMed    
    
    
    
74. CHARLES P, Ditac G, Montoy M, Thenard T, et al
    Intra-pocket ultrasound-guided axillary vein puncture vs. cephalic vein cutdown for cardiac electronic device implantation: the ACCESS trial.
    Eur Heart J. 2023;44:4847-4858.
    PubMed     Abstract available
    
    
    
75. LI J, Li Q, Shu C
    Aortic intimal intussusception induced by stent-graft during endovascular repair of acute type B aortic dissection.
    Eur Heart J. 2023;44:4813.
    PubMed    
    
    
    November 2023
76. VERGALLO R, Volpe M
    Optical coherence tomography to guide percutaneous coronary intervention: is the glass half full or half empty?
    Eur Heart J. 2023 Nov 28:ehad792. doi: 10.1093.
    PubMed    
    
    
    
77. ZHAO Y, Chen Y
    What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
    Eur Heart J. 2023 Nov 20:ehad728. doi: 10.1093.
    PubMed    
    
    
    
78. PEDICINO D, Liuzzo G
    Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
    Eur Heart J. 2023 Nov 18:ehad733. doi: 10.1093.
    PubMed    
    
    
    
79. GARCIA-MOLL X
    Where there is smoke there is risk: is there an irreversible threshold?
    Eur Heart J. 2023;44:4473-4475.
    PubMed    
    
    
    
80. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
    Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
    Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
    PubMed    
    
    
    
81. KIM H, Kang DY, Lee J, Choi Y, et al
    Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
    Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. CREA F
    Hot topics in interventional cardiology: left main disease, heavily calcified coronary stenoses, and physiology-guided percutaneous coronary interventions.
    Eur Heart J. 2023;44:4295-4299.
    PubMed    
    
    
    
83. BYRNE RA, Fremes S, Capodanno D, Czerny M, et al
    2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Eur Heart J. 2023;44:4310-4320.
    PubMed     Abstract available
    
    
    
84. JOHNSON NP, Ahn JM
    Left main PCI: beware the circumflex!
    Eur Heart J. 2023;44:4337-4339.
    PubMed    
    
    
    
85. BARBATO E, Gallinoro E, Abdel-Wahab M, Andreini D, et al
    Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group.
    Eur Heart J. 2023;44:4340-4356.
    PubMed     Abstract available
    
    
    
86. WANG HY, Zhang R, Dou K, Huang Y, et al
    Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality.
    Eur Heart J. 2023;44:4324-4336.
    PubMed     Abstract available
    
    
    October 2023
87. ALI ZA, Shin D
    Intravascular imaging: a glass half empty or half full?
    Eur Heart J. 2023;44:3856-3858.
    PubMed    
    
    
    September 2023
88. KI YJ, Han K, Kim HS, Han JK, et al
    Smoking and cardiovascular outcomes after percutaneous coronary intervention: a Korean study.
    Eur Heart J. 2023 Sep 26:ehad616. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
89. FAZEL R, Yeh RW, Cohen DJ, Rao SV, et al
    Intravascular imaging during percutaneous coronary intervention: temporal trends and clinical outcomes in the USA.
    Eur Heart J. 2023 Jul 19:ehad430. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
90. COLOMBO A, Leone PP
    Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.
    Eur Heart J. 2023 Apr 11:ehad215. doi: 10.1093.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge.